Overview

World Health Organization (WHO) has just released the Integrated Guidelines on the Clinical Management of Arboviral Diseases — a crucial step toward strengthening care for the millions of people affected by these viruses each year.

Arboviral diseases, primarily transmitted by Aedes mosquitoes, pose an increasing threat to global health, particularly in the context of climate change, urbanization, and growing human mobility. With over 5.6 billion people worldwide at risk of arboviral infection, it is essential that healthcare professionals have access to evidence-based recommendations to effectively manage these infections in patients.

The new WHO guidelines provide clinical management recommendations for four of the most widespread arboviruses affecting humans: dengue, chikungunya, Zika, and yellow fever.

An integrated approach is vital, as these four diseases often present with similar symptoms, especially in the early stages of infection, and multiple arboviruses may circulate simultaneously in certain regions. This makes clinical differentiation challenging, particularly where diagnostic testing is not readily available.

<아르보바이러스 질병(뎅기열, 치쿤구니야열, 지카열 및 황열병) 임상 관리에 대한 WHO 가이드라인>

본 WHO 자료는 아르보바이러스 질병의 임상 관리에 대한 통합 가이드라인으로, 인간에게 가장 널리 퍼진 뎅기열, 치쿤구니야열, 지카열 및 황열병에 대한 임상 관리 지침을 제공한다.
해당 질병들은 감염 초기에 유사한 증상을 보이며, 특정 지역에선 동시에 유행할 수 있으므로 이에 대한 통합적인 접근이 필요하다고 강조한다.

원문 링크: https://www.who.int/publications/i/item/9789240111110